|
ISPD membership includes complimentary access to the Prenatal Diagnosis journal, membership in Special Interest Groups, a searchable Member Directory discounted conference registration rates, exclusive access to online content and more!
|
 |
|
2021 Update from the Board of Directors
|
|
|
|
|
|
Lyn Chitty, PhD, MRCOG
As we start the New Year, I am sure that we are all relieved to have left 2020 behind. This time last year none of could have imagined the changes that have occurred in our lives in the last 12 months. We can only hope that 2021 brings better things, although for many of us times remain very challenging. However, on behalf of the ISPD Board of Directors, I would like to offer you my best wishes as we move into 2021.
As a Board, we are committed to offering our members and non-member colleagues valuable resources and education to help further our mission of advancing the science and practice of genetics and fetal care worldwide by promoting the health of children, their mothers, and their families. We have a variety of programs planned for 2021, highlighted by the 2021 International Conference on Prenatal Diagnosis and Therapy, which will be held virtually 6-8 June 2021. Please mark your calendar and consider submitting an abstract for presentation and publication as a part of this unique meeting. Live panel discussions will be offered in two different time zones, and the conference will include sessions on hot topics, invited talks on the latest research, and our exciting debates.
We are also planning to hold several of our popular training courses virtually throughout the year, along with awebinar seriesfocused on articles of interest that appear in Prenatal Diagnosis.
Finally, we are pleased to announce that we will be launchingISPD Connect, which is a robust member engagement platform that allows for members to pose questions, share resources, and inquire after collaborators online.
Please watch for information in your email about all these opportunities and contact ISPD Headquarters with any questions. We look forward to your participation!
|
|
|
|
|
 |
|
|
|
2020 ISPD Virtual Education Series
|
|
|
|
|
|
Thank you for your support of our series of educational webinars on Wednesdays in October-December 2020. If you missed a session, all VES Recordings are available open access on the ISPD website. Also, physicians may still claim and receive CME credit.
VES TOPICS
- Hottest Topics: CRISPR
- TOTAL Trial
- Debate 1: Fetuses with non-isolated fetal anomalies or genetic syndromes should be excluded from fetal therapy.
- Debate 2: Expanded NIPT that includes conditions other than trisomies 13, 18, and 21 should be offered.
- Functional Imaging
- Genetic Counseling
|
|
|
|
|
Right or wrong? Looking through the retrospectoscope to analyse predictions made a decade ago in prenatal diagnosis and fetal surgery
|
|
|
|
|
|
The Prenatal Diagnosis editors have summarized the most important innovations in the field of prenatal diagnosis and fetal therapy over the past 10 years in a brief editorial freely available through Wiley online.
|
|
|
|
|
Best of the Prenatal Diagnosis Journal - Editor's Choice Articles in 2020
|
|
|
|
|
|
|
|
June (Issue 7)
Monochorionic diamniotic twins: What do I tell the prospective parents?
Liesbeth Lewi
July (Issue 8)
The fragmentation patterns of maternal plasma cell‐free DNA and its applications in non‐invasive prenatal testing
Min Pan, Pingsheng Chen, Jiafeng Lu et al.
August (Issue 9)
Approaches to studying the genomic architecture of complex birth defects
Toluwani E. Taiwo, Xuanye Cao, Robert M. Cabrera et al
September (Issue 10)
Fetal brain, head, and neck tumors: Prenatal imaging and management
Tamara Feygin, Nahla Khalek, Julie S. Moldenhauer
October (Issue 11)
Discordant fetal sex on NIPT and ultrasound
Maria‐Elisabeth Smet, Fergus P. Scott, Andrew C. McLennan
November (Issue 12)
Fetal spina bifida: What we tell the parents
Lara Gotha, Vagisha Pruthi, Nimrah Abbasi et al.
December (Issue 13)
Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS‐CoV‐2s.
Aniza P. Mahyuddin, Abhiram Kanneganti, Jeslyn J.L. Wong, et al.
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
Prenatal Diagnosis Journal - Recent Issues
|
|
|
|
|
|
Volume 40 | Issue 13 | December 2020 | 40th Anniversary Issue
Editor's Choice Article:
Mahyuddin, AP, Kanneganti, A, Wong, JJL, et al. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS‐CoV‐2s. DOI: 10.1002/pd.5765
|
|
|
|
|
|
|
Volume 40 | Issue 12 | November 2020
Editor's Choice Article:
Gotha, L, Pruthi, V, Abbasi, N, et al. Fetal spina bifida: What we tell the parents. DOI: 10.1002/pd.5802
|
|
|
|
|
ISPD members have online access to all Prenatal Diagnosis articles via the ISPD website.
|
|
|
|
|
|
|
|
|
|
ISPD Global Updates Editors
Lynn Bush (USA)
Lisa Hui (Australia)
Florencia Petracchi (Argentina)
Neeta Vora (USA)
Read Editor Biographies
Global Updates Board Liaisons:
Neeta Vora (USA)
Louise Wilkins-Haug (USA)
Past eNewsletters
Past issues of Global Updates are available on our eNewsletter Archives Page.
Also available on that page are issues of our previous eNewsletter, Prenatal Perspectives.
***Call for Editors***
Would you like to contribute to ISPD through the publication of Global Updates? We are seeking additional editors to review and solicit content in partnership with SIG leaders and ISPD Headquarters. Contact Erin Irtenkauf at eirtenkauf@ispdhome.org for details.
|
|
|
|
|
|
|
|
|
|
|
ISPD Board of Directors
Officers
Lyn S. Chitty, President (UK)
Mahesh A. Choolani, President-Elect
. (Singapore)
Rossa Chiu, Secretary (Hong Kong)
Lee Shulman, Treasurer (USA)
Louise E. Wilkins-Haug, Past President (USA)
|
|
|
|
|
|
Directors
April Adams (USA)
Lisa Hui (Australia)
Maria L. Igarzabal (Argentina)
Brynn Levy (USA)
Mark Pertile (Australia)
Tim Van Mieghem (Canada)
Neeta L. Vora (USA)
|
|
|
|
|
|
|
|
|
|
|
ISPD joins other professional societies and healthcare organizations in condemning prejudice, discrimination, and racial injustice. We are committed to promoting diversity among our members consistent with our vision that evidence-based practice and culturally sensitive preconception and prenatal screening, diagnostics, and therapy are available to all families.
|
|
|
|
|
|
|